AtriCure Inc (ATRC)
22.56
+0.30
(+1.35%)
USD |
NASDAQ |
May 31, 16:00
22.55
-0.01
(-0.04%)
After-Hours: 20:00
AtriCure Research and Development Expense (TTM): 78.43M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 78.43M |
| December 31, 2023 | 73.92M |
| September 30, 2023 | 66.87M |
| June 30, 2023 | 61.68M |
| March 31, 2023 | 59.04M |
| December 31, 2022 | 57.34M |
| September 30, 2022 | 57.40M |
| June 30, 2022 | 53.51M |
| March 31, 2022 | 50.92M |
| December 31, 2021 | 48.51M |
| September 30, 2021 | 45.57M |
| June 30, 2021 | 44.86M |
| March 31, 2021 | 42.70M |
| December 31, 2020 | 43.07M |
| September 30, 2020 | 45.30M |
| June 30, 2020 | 44.87M |
| March 31, 2020 | 44.64M |
| December 31, 2019 | 41.23M |
| September 30, 2019 | 36.59M |
| June 30, 2019 | 34.99M |
| March 31, 2019 | 33.84M |
| December 31, 2018 | 34.72M |
| September 30, 2018 | 33.99M |
| June 30, 2018 | 33.40M |
| March 31, 2018 | 33.65M |
| Date | Value |
|---|---|
| December 31, 2017 | 34.14M |
| September 30, 2017 | 36.29M |
| June 30, 2017 | 36.59M |
| March 31, 2017 | 36.81M |
| December 31, 2016 | 35.82M |
| September 30, 2016 | 33.72M |
| June 30, 2016 | 31.96M |
| March 31, 2016 | 28.70M |
| December 31, 2015 | 25.74M |
| September 30, 2015 | 22.97M |
| June 30, 2015 | 21.50M |
| March 31, 2015 | 20.21M |
| December 31, 2014 | 18.60M |
| September 30, 2014 | 17.25M |
| June 30, 2014 | 15.46M |
| March 31, 2014 | 13.94M |
| December 31, 2013 | 13.44M |
| September 30, 2013 | 12.76M |
| June 30, 2013 | 12.43M |
| March 31, 2013 | 12.26M |
| December 31, 2012 | 12.15M |
| September 30, 2012 | 12.14M |
| June 30, 2012 | 12.31M |
| March 31, 2012 | 12.30M |
| December 31, 2011 | 11.86M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
34.99M
Minimum
Jun 2019
78.43M
Maximum
Mar 2024
51.57M
Average
47.04M
Median
Research and Development Expense (TTM) Benchmarks
| Alphatec Holdings Inc | 74.87M |
| Intuitive Surgical Inc | 1.038B |
| LeMaitre Vascular Inc | 17.18M |
| iRhythm Technologies Inc | 62.40M |
| RxSight Inc | 29.87M |